logo-loader
viewRedx Pharma PLC

Redx Pharma chief elected to industry body role

From the start of 2019, Lisa Anson will serve as a director of the UK BioIndustry Association for a three-year term

lisa anson
The Redx boss (in a former role as president of the Association of the British Pharmaceutical Industry) said she was "delighted" to be elected to the BIA board

Redx Pharma Plc (LON:REDX) has confirmed its chief executive, Lisa Anson, has been elected to senior industry role.

From the start of 2019, she will serve as a director of the UK BioIndustry Association for a three-year term.

READ: Redx Pharma to focus on progressing oncology and fibrotic drugs in 2019

"I am delighted to be elected to join the BIA Board,” said Anson.

“I am passionate about the UK Biotech sector, as it is not only the focus for much of the exciting science in the UK, but it is also an important sector supporting the UK economy.

“Having previously been president of the Association of the British Pharmaceutical Industry (ABPI), I am personally excited at the prospect of working with the BIA to further the industry."

Quick facts: Redx Pharma PLC

Price: 30 GBX

AIM:REDX
Market: AIM
Market Cap: £57 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redx Pharma PLC named herein, including the promotion by the Company of Redx Pharma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Redx Pharma 'on a firm footing and able to drive its business plan'...

Redx Pharma PLC's (LON:REDX) Lisa Anson caught up with Proactive London's Andrew Scott after announcing they've raised US$30mln via the issue of convertible loan notes. Funds Redmile Group and Sofinnova Partners are putting up US$19mln and US$10mln respectively. The cash will be used to...

2 weeks, 2 days ago

2 min read